Brain Scientific Statistics
Total Valuation
BRSF has a market cap or net worth of 931,985. The enterprise value is 3.05 million.
| Market Cap | 931,985 |
| Enterprise Value | 3.05M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
BRSF has 1.24 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 1.24M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.10% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.34 |
| PB Ratio | 0.22 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.25 |
| EV / Sales | 14.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.51 |
Financial Position
The company has a current ratio of 0.18, with a Debt / Equity ratio of 0.66.
| Current Ratio | 0.18 |
| Quick Ratio | 0.10 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.48 |
| Interest Coverage | -2.67 |
Financial Efficiency
Return on equity (ROE) is -681.55% and return on invested capital (ROIC) is -70.09%.
| Return on Equity (ROE) | -681.55% |
| Return on Assets (ROA) | -47.81% |
| Return on Invested Capital (ROIC) | -70.09% |
| Return on Capital Employed (ROCE) | -222.18% |
| Revenue Per Employee | 19,506 |
| Profits Per Employee | -1.12M |
| Employee Count | 11 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.63 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.25 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.75 |
| 200-Day Moving Average | 0.75 |
| Relative Strength Index (RSI) | 13.59 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BRSF had revenue of 214,564 and -12.34 million in losses. Loss per share was -12.95.
| Revenue | 214,564 |
| Gross Profit | 54,325 |
| Operating Income | -9.61M |
| Pretax Income | -12.34M |
| Net Income | -12.34M |
| EBITDA | -8.78M |
| EBIT | -9.61M |
| Loss Per Share | -12.95 |
Balance Sheet
The company has 747,714 in cash and 2.86 million in debt, giving a net cash position of -2.12 million or -1.70 per share.
| Cash & Cash Equivalents | 747,714 |
| Total Debt | 2.86M |
| Net Cash | -2.12M |
| Net Cash Per Share | -1.70 |
| Equity (Book Value) | 4.32M |
| Book Value Per Share | 3.47 |
| Working Capital | -6.11M |
Cash Flow
In the last 12 months, operating cash flow was -5.94 million and capital expenditures -33,293, giving a free cash flow of -5.97 million.
| Operating Cash Flow | -5.94M |
| Capital Expenditures | -33,293 |
| Free Cash Flow | -5.97M |
| FCF Per Share | -4.80 |
Margins
| Gross Margin | 25.32% |
| Operating Margin | -4,478.11% |
| Pretax Margin | -5,753.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BRSF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -162.25% |
| Shareholder Yield | -162.25% |
| Earnings Yield | -1,324.47% |
| FCF Yield | -640.39% |
Stock Splits
The last stock split was on February 3, 2023. It was a reverse split with a ratio of 0.0117647.
| Last Split Date | Feb 3, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.0117647 |
Scores
BRSF has an Altman Z-Score of -6.32. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.32 |
| Piotroski F-Score | n/a |